Marta Francesca Di Pasquale
A5003880636- Pneumonia and Respiratory Infections
- Pneumocystis jirovecii pneumonia detection and treatment
- Respiratory viral infections research
- Long-Term Effects of COVID-19
- Mycobacterium research and diagnosis
- Antifungal resistance and susceptibility
- Influenza Virus Research Studies
- Neutropenia and Cancer Infections
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2018-2019
University of Milan
2018-2019
Sociedad Española de Neumología y Cirugía Torácica
2012
The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics coming from community pneumonia.We conducted a secondary analysis an international, multicenter study enrolling adult hospitalized in 222 hospitals 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic...
Introduction: Novel cuffs made of polyurethane or with a tapered shape were devised to overcome fluid-sealing limitations. However, no studies have assessed potential tracheal injury associated these cuffs. Hypothesis: We bronchoscopically produced by HVLP following 72 hours intubation and after 24 96 from extubation. Methods: 16 pigs (Kg 39 ± 3) intubated 7.0 ETTs comprising cylindrical, PVC cuffs: ETT1 Ruschelit® Safety Clear plus (2 pigs), ETT2 Hi-LoTM pigs); cylindrical cuff: ETT3...
Introduction: Following tracheal intubation and endotracheal tube (ETT) cuff inflation, mucociliary clearance rate (MCR) is drastically reduced (1). Hypothesis: We assessed the effects on MCR of ETTs comprising high-volume low-pressure (HVLP) cuffs different designs materials. Methods: 16 pigs (Kg 38.9 ± 3.4) were intubated with 7.0 cylindrical, PVC cuffs: ETT1 Ruschelit® Safety Clear plus (2 pigs), ETT2 Hi-LoTM pigs); cylindrical polyurethane cuff: ETT3 Kimvent Microcuff conical ETT4...
<b>Background:</b> The correct management of immunosuppressed patients with pneumonia is debated. We evaluate prevalence, risk factors and characteristics coming from the community <b>Methods:</b> A secondary analysis an international, multicenter study enrolling adult hospitalized in 222 hospitals 54 countries worldwide was conducted. Risk for immunosuppression included: AIDS, aplastic anemia, asplenia, hematological malignancy, chemotherapy, neutropenia, biological drug use, lung...